Cabot Corporation Common Stock (CBT)
84.35
+0.00 (0.00%)
NYSE · Last Trade: Apr 3rd, 5:49 AM EDT

We are looking for value in the Materials Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty valuations ever.
Via Talk Markets · December 26, 2024

Stocks are higher as the market rebounds from a staggering global selloff.
Via Talk Markets · August 6, 2024

Via Benzinga · August 6, 2024

CBT stock results show that Cabot beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via InvestorPlace · August 5, 2024

CBT stock results show that Cabot beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · May 6, 2024

The materials sector might witness a turnaround, boosted by robust supply-demand dynamics in 2024. Fidelity identifies 5 stock picks.
Via Benzinga · January 10, 2024

Via Benzinga · November 17, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via Benzinga · November 6, 2023

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million.
Via Benzinga · February 5, 2024

An analysis of materials stocks.
Via Talk Markets · January 3, 2024

Cabot Corp (NYSE: CBT) disclosed the impact of the current demand environment
Via Benzinga · June 16, 2023

A real estate bankruptcy shakes confidence in China and consumers across the globe focus on lower-priced items.
Via The Motley Fool · August 26, 2023

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via Benzinga · June 16, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording losses in today’s session. Coherus BioSciences, Inc. (NASDAQ: CHRS) tumbled 16.8% to $4.48. Coherus BioSciences agreed to acquire
Via Benzinga · June 16, 2023

Via Benzinga · June 6, 2023